Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Oxaprozin

21256-18-8C18H15NO3293.322 g/mol

A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number21256-18-8ChEBI ↗
Molecular formulaC18H15NO3ChEBI ↗
Molar mass293.322 g/molChEBI ↗
Monoisotopic mass293.10519 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:7822ChEBI ↗

Cross-source molecular data

PubChem
Molar mass293.3 g/molPubChem ↗
Exact mass293.10519334 DaPubChem ↗
Computed XLogP4.2PubChem ↗
Topological polar surface area (Ų)63.3PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors4PubChem ↗
Rotatable bonds5PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
oxaprozin
3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid
OFPXSFXSNFPTHF-UHFFFAOYSA-N
O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1
InChI=1S/C18H15NO3/c20-16(21)12-11-15-19-17(13-7-3-1-4-8-13)18(22-15)14-9-5-2-6-10-14/h1-10H,11-12H2,(H,20,21)

Names & synonyms

3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acidDanoproxDayproDayrunDeflamDuraproxoxaprozinaoxaprozineoxaprozinumWalix

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

non-steroidal anti-inflammatory druganalgesicantirheumatic drug

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00340922 mol

Uses 293.322 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 18 atoms
73.71%
O
Oxygen · 3 atoms
16.36%
H
Hydrogen · 15 atoms
5.15%
N
Nitrogen · 1 atom
4.78%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
Oxaprozin: a new NSAID. ↗Orthopaedic review · 1992 May · PMID 1603605
Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug. ↗Clinical pharmacy · 1992 Jul · PMID 1617910
FR2001036 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
GB1206403 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3578671 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:7822

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 4614 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.